Pharmaceuticals News

Browse the latest Pharmaceuticals news. Use the menu or navigation tiles to change industry or topic.

January 23, 2026 07:30 ET | Source: Sanara MedTech Inc.

Sanara MedTech Inc. Reports Unaudited Preliminary Financial Results for the Fourth Quarter and Full Year 2025; Introduces Full Year 2026 Financial Guidance

FORT WORTH, TX, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara MedTech,” “Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on...
January 23, 2026 07:00 ET | Source: OKYO Pharma LTD

FDA Approves Compassionate Use of Urcosimod (0.05%) for the Treatment of Neuropathic Corneal Pain

LONDON and NEW YORK, Jan. 23, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of...
January 23, 2026 07:00 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Presents Long-Term Phase 1b Data for Tegoprubart in Kidney Transplant Patients at the American Society of Transplant Surgeons Winter Symposium

Eledon Pharmaceuticals Presents Long-Term Phase 1b Data for Tegoprubart in Kidney Transplant Patients at ASTS
January 23, 2026 07:00 ET | Source: NextCure

NextCure Provides Business Update

SIM0505 (CDH6 ADC) Phase 1 dose escalation data update anticipated in Q2 2026LNCB74 (B7-H4 ADC) Phase 1 dose escalation expanded into higher dose cohorts BELTSVILLE, Md., Jan. 23, 2026 (GLOBE...
January 23, 2026 02:00 ET | Source: Bavarian Nordic A/S

Bavarian Nordic indgår distributionsaftale med Eurofarma for at udvide adgangen til chikungunya-vacciner i Brasilien

Aftalen muliggør den første markedslancering i Latinamerika for Bavarian Nordics chikungunya‑vaccineRummer mulighed for udvidelse til at dække resten af Latinamerika KØBENHAVN, Danmark, 23. januar...
January 23, 2026 02:00 ET | Source: Bavarian Nordic A/S

Bavarian Nordic Signs Distribution Agreement with Eurofarma to Expand Access to Chikungunya Vaccine in Brazil

Bavarian Nordic has signed a distribution agreement with Eurofarma for its chikungunya vaccine in Brazil with potential to expand to rest of Latin America
January 23, 2026 01:00 ET | Source: Sanofi Winthrop Industrie

Communiqué de presse : L’amlitelimab de Sanofi confirme son potentiel dans la dermatite atopique

L’amlitelimab de Sanofi confirme son potentiel dans la dermatite atopique Dans l'étude de phase 3 SHORE, l'amlitelimab en association avec des traitements topiques a atteint tous les critères...
January 23, 2026 01:00 ET | Source: Sanofi Winthrop Industrie

Press Release: Sanofi's amlitelimab confirms its potential in atopic dermatitis

Sanofi's amlitelimab confirms its potential in atopic dermatitis In the SHORE phase 3 study, amlitelimab in combination with topical therapies met all primary and key secondary endpoints at Week 24...
January 22, 2026 17:00 ET | Source: Vaxcyte, Inc.

Vaxcyte Advances Adult and Infant Programs for VAX-31, a Potential Best-in-Class, Next-Generation Pneumococcal Conjugate Vaccine

VAX-31 Adult Indication: Vaxcyte Doses First Participants in Phase 3 Study Evaluating Concomitant Administration of VAX-31 and Seasonal Influenza Vaccine (OPUS-2) and Expects to Initiate Phase 3 Study...
January 22, 2026 16:05 ET | Source: Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

CONSHOHOCKEN, Pa., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic...